Fernández-Reyes M J, Bajo Rubio M A, del Peso Gilzanz G, Estrada P, Sousa S, Sánchez-Villanueva R, Heras M, Ossorio M, Sánchez-Vega C, Selgas R
Servicio de Nefrología, Hospital General de Segovia y Hospital Universitario La Paz, Madrid, Spain.
Nefrologia. 2010;30(2):208-13. doi: 10.3265/Nefrologia.pre2010.Mar.10333.
The use of solutions containing hypertonic glucose (3.86%/4.25%) has been postulated as the method of choice for study the peritoneal function, and permits a better evaluation of the ultrafiltration (UF) capacity.
The aim of our study was to analyze the UF capacity and its relation with the peritoneal permeability and sieving of sodium, performing the peritoneal kinetic study with hypertonic glucose solutions.
We performed 184 peritoneal kinetic studies with hypertonic glucose solutions in stable patients on peritoneal dialysis (PD), with a mean time on PD of 16 +/- 22 months. We measured the mass transfer coefficient of creatinine (CrMTC), dialysate to plasma ratio of creatinine (D/PCr), UF capacity and sieving of sodium at 60 minutes (difNa60).
The mean values were: CrMTC: 9.1 +/- 4.5 ml/min, D/PCr: 0.71 +/- 0.09, UF 759 +/- 233 ml/4 h and difNa60: 4.7 +/- 2.3. The best multivariate model that predicts the UF capacity included: difNa60, CrMTC, age and time on PD (r = 0.57; p > 0.0001). In patients with UF lower than 600 ml/4 h (Percentil 25) the correlation between UF and CrMTC was lost, but remains the correlation with difNa60 (r = 0.48). The patients with previous peritonitis (n = 38) showed no differences in UF, CrMTC or D/Pcr, but the had lower difNa60 (3.7 +/- 2.8 vs. 4.9 +/- 2.1; p = 0.002) than the remaining patients.
The peritoneal kinetic study performed with hypertonic glucose allows to standardize the UF capacity and by determination of sieving of sodium, the early detection of water transport alterations, before the UF capacity and small solutes permeability alteration develops.
含高渗葡萄糖(3.86%/4.25%)的溶液已被假定为研究腹膜功能的首选方法,并且能更好地评估超滤(UF)能力。
我们研究的目的是通过使用高渗葡萄糖溶液进行腹膜动力学研究,分析超滤能力及其与腹膜通透性和钠筛过的关系。
我们对184例稳定的腹膜透析(PD)患者使用高渗葡萄糖溶液进行了腹膜动力学研究,这些患者的PD平均时间为16±22个月。我们测量了肌酐的质量转运系数(CrMTC)、肌酐的透析液与血浆比值(D/PCr)、超滤能力以及60分钟时钠的筛过率(difNa60)。
平均值为:CrMTC:9.1±4.5 ml/分钟,D/PCr:0.71±0.09,超滤759±233 ml/4小时,difNa60:4.7±2.3。预测超滤能力的最佳多变量模型包括:difNa60、CrMTC、年龄和PD时间(r = 0.57;p>0.0001)。在超滤低于600 ml/4小时(第25百分位数)的患者中,超滤与CrMTC之间的相关性消失,但与difNa60的相关性仍然存在(r = 0.48)。既往有腹膜炎的患者(n = 38)在超滤、CrMTC或D/Pcr方面无差异,但他们的difNa60低于其余患者(3.7±2.8对4.9±2.1;p = 0.002)。
使用高渗葡萄糖进行腹膜动力学研究可使超滤能力标准化,并通过测定钠的筛过率,在超滤能力和小分子溶质通透性改变出现之前,早期检测水转运改变。